Similar Search Results

The Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France

Lichtenberg, Frank R. - 2014

I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I …-2006. The estimates imply that chemotherapy innovation accounted for at least one-sixth of the decline in French cancer …

Persistent link: https://www.econbiz.de/10013069689

The Italian Start Up Act : a microeconometric program evaluation

Biancalani, Francesco; Czarnitzki, Dirk; Riccaboni, Massimo - In: Small business economics : an international journal 58 (2022) 3, pp. 1699-1720

Persistent link: https://www.econbiz.de/10012819291

The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996-2019

Lichtenberg, Frank R. - In: Swiss journal of economics and statistics 158 (2022) 1, pp. 1-24

We analyze the association that pharmaceutical innovation had with premature mortality from all diseases in Switzerland … 2002-2019. The analysis is performed by investigating whether the diseases that experienced more pharmaceutical innovation … had larger subsequent declines in premature mortality and hospitalization. Pharmaceutical innovation is measured by the …

Persistent link: https://www.econbiz.de/10013177259

The Impact of New Drug Launches on Longevity : Evidence from Longitudinal Disease-Level Data from 52 Countries, 1982-2001

Lichtenberg, Frank R. - 2021

We perform an econometric analysis of the effect of new drug launches on longevity, using data from the IMS Health Drug Launches database and the WHO Mortality Database. Our data cover virtually all of the diseases borne by people in 52 countries during the period 1982-2001, and enable us to...

Persistent link: https://www.econbiz.de/10013245298